Eslicarbazepine
- Generic Name
- Eslicarbazepine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H14N2O2
- CAS Number
- 104746-04-5
- Unique Ingredient Identifier
- S5VXA428R4
- Background
Eslicarbazepine is an anti-epileptic medication available commercially as eslicarbazepine acetate.
- Associated Conditions
- -
- Associated Therapies
- -
Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults
- First Posted Date
- 2016-09-23
- Last Posted Date
- 2019-06-04
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 46
- Registration Number
- NCT02912364
- Locations
- 🇺🇸
Stanford University, Palo Alto, California, United States
Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-04-30
- Last Posted Date
- 2013-09-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 6498
- Registration Number
- NCT01587339
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath